Occupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Integrative Tumor Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Nat Genet. 2024 May;56(5):809-818. doi: 10.1038/s41588-024-01725-7. Epub 2024 Apr 26.
Here, in a multi-ancestry genome-wide association study meta-analysis of kidney cancer (29,020 cases and 835,670 controls), we identified 63 susceptibility regions (50 novel) containing 108 independent risk loci. In analyses stratified by subtype, 52 regions (78 loci) were associated with clear cell renal cell carcinoma (RCC) and 6 regions (7 loci) with papillary RCC. Notably, we report a variant common in African ancestry individuals ( rs7629500 ) in the 3' untranslated region of VHL, nearly tripling clear cell RCC risk (odds ratio 2.72, 95% confidence interval 2.23-3.30). In cis-expression quantitative trait locus analyses, 48 variants from 34 regions point toward 83 candidate genes. Enrichment of hypoxia-inducible factor-binding sites underscores the importance of hypoxia-related mechanisms in kidney cancer. Our results advance understanding of the genetic architecture of kidney cancer, provide clues for functional investigation and enable generation of a validated polygenic risk score with an estimated area under the curve of 0.65 (0.74 including risk factors) among European ancestry individuals.
在这里,我们进行了一项多血统全基因组关联研究荟萃分析,研究对象为肾癌(29020 例病例和 835670 例对照),确定了包含 108 个独立风险位点的 63 个易感性区域(50 个新发现的)。在按亚型分层的分析中,52 个区域(78 个位点)与透明细胞肾细胞癌(RCC)相关,6 个区域(7 个位点)与乳头状 RCC 相关。值得注意的是,我们报告了一个在非洲血统个体中常见的变体(rs7629500),位于 VHL 的 3'非翻译区,使透明细胞 RCC 的风险几乎增加了三倍(优势比 2.72,95%置信区间 2.23-3.30)。在顺式表达数量性状基因座分析中,来自 34 个区域的 48 个变体指向 83 个候选基因。缺氧诱导因子结合位点的富集突出了缺氧相关机制在肾癌中的重要性。我们的研究结果提高了对肾癌遗传结构的认识,为功能研究提供了线索,并能够生成一个经过验证的多基因风险评分,在欧洲血统个体中的曲线下面积估计为 0.65(包括风险因素为 0.74)。
Cancer Epidemiol Biomarkers Prev. 2013-11-12
Int J Clin Exp Pathol. 2015-5-1
Transl Androl Urol. 2025-3-30
Biomedicines. 2024-7-30
ArXiv. 2024-7-3
Nat Commun. 2023-1-21
Trends Cell Biol. 2023-7
PLoS Genet. 2022-7
Hum Mol Genet. 2022-8-23